News

TD Cowen Reaffirms Their Buy Rating on Xenon (XENE)

Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.

Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead The Charge In Pioneering New Treatments Delveinsight

Cannabinoids are specific chemical compounds found in cannabis, such as tetrahydrocannabinol (THC) and cannabidiol (CBD). Research is increasingly su ...

The Best Small-Cap Stocks to Buy Now

The second half of 2025 could be much more favorable for stockpickers looking for the best small-cap stocks to buy.That might ...

Mizuho Securities Sticks to Their Buy Rating for Insmed (INSM)

In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Insmed, with a price target of $130.00. The company’s shares opened today at $109.83. Take advantage of ...